73.8% of the patients with IBD have received steroids. 71.8% of the patients with ulcerative colitis received steroids at some point in the course of the disease, while 87.5% of the individuals with Crohns disease and 57.1% of the patients with IBDU were treated with steroids.
En cuanto al uso de las diferentes formas de presentación de 5-ASA en colitis ulcerativa, se utilizó 5-ASA oral en 93,2% y tópico en 6,8%, en cuanto a la extensión, los pacientes con proctitis recibieron tratamiento tópico en solo 24,1% de los casos.